Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

CD49d Is The Strongest Flow Cytometry-Based Predictor Of Overall Survival In Chronic Lymphocytic Leukemia

Pietro Bulian, MD, Tait D Shanafelt, MD, Chris Fegan, MBBS, Antonella Zucchetto, Lilla Cro, PhD, Holger Nuckel, MD, Luca Baldini, Antonina Kurtova, MS, Alessandra Ferrajoli, MD, Jan A. Burger, MD, PhD, Gianluca Gaidano, Giovanni Del Poeta, MD, Chris Pepper, Ph.D., Davide Rossi, Valter Gattei

Blood (2013) 122 (21): 672.

https://doi.org/10.1182/blood.V122.21.672.672

Published: 2013

Journal Articles

Prognostic Relevance of CD49d Expression On B Leukemic Cells in Chronic Lymphocytic Leukemia. Meta-Analysis of Published and unpublished Individual Data From 3146 Patients

Pietro Bulian, MD, Tait D. Shanafelt, MD, Chris Pepper, Chris Fegan, Giovanni Del Poeta, Gianluca Gaidano, MD, PhD, Davide Rossi, MD, PhD, Luca Baldini, Lilla Cro, PhD, Holger Nuckel, MD, Jan A. Burger, MD, PhD, Valter Gattei, MD

Blood (2012) 120 (21): 3871.

https://doi.org/10.1182/blood.V120.21.3871.3871

Published: 2012

Journal Articles

Indolent B-Cell Lymphomas Treated Upfront with Antiviral Therapy: a Series of 13 Patients

Andrea Ferrario, MD, Alessio Aghemo, MD, Maria Cecilia Goldaniga, MD, Michele Merli, MD, Daniele Vincenti, MD, Francesca Gaia Rossi, MD, Elisabetta De Gasperi, MD, Barbara Olivero, MD, Lilla Cro, PhD, Sara Rattotti, MD, Luca Arcaini, MD, Francesco Onida, MD, Luca Baldini, Prof

Blood (2010) 116 (21): 2876.

https://doi.org/10.1182/blood.V116.21.2876.2876

Published: 2010

Journal Articles

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative.

Andrea Ferrario, MD, Lilla Cro, PhD, Nadia Zucal, Marta Lionetti, PhD, Francesco Bertoni, MD, Lucia Nobili, PhD, Sonia Fabris, PhD, Katia Todoerti, PhD, Fortunato Morabito, MD, Giovanna Cutrona, PhD, Agostino Cortelezzi, MD, Andrea Guffanti, MD, Maria Cecilia Goldaniga, MD, Stefano Luminari, MD, Luigi Marcheselli, PhD, Manlio Ferrarini, MD, Antonino Neri, MD, Giorgio Lambertenghi Deliliers, MD, Luca Baldini, MD

Blood (2009) 114 (22): 1259.

https://doi.org/10.1182/blood.V114.22.1259.1259

Published: 2009

Journal Articles

Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors

Lilla Cro, PhD, Andrea Ferrario, MD, Nadia Zucal, Umberto Gianelli, MD, Sonia Fabris, PhD, Lucia Nobili, PhD, Barbara Olivero, MD, Francesca G Rossi, MD, Luca Baldini, MD, Giorgio Lambertenghi Deliliers, MD

Blood (2008) 112 (11): 5286.

https://doi.org/10.1182/blood.V112.11.5286.5286

Published: 2008

Journal Articles

The Cytofluorimetric/FISH Diagnostic Approach Define a B-Cell Variant-CLL with Peculiar Clinico-Biological Features.

Lilla Cro, Luca Baldini, Lucia Nobili, Antonino Neri, Nadia Zucal, Andrea Ferrario, Marta Lionetti, Francesco Bertoni, Fortunato Morabito, Andrea Guffanti, Maria Goldaniga, Giovanna Cutrona, Agostino Cortelezzi, Stefano Luminari8, Manlio Ferrarini, Giorgio Lambertenghi Deliliers

Blood (2007) 110 (11): 2077.

https://doi.org/10.1182/blood.V110.11.2077.2077

Published: 2007

Journal Articles

CD26 Expression in Mature B-Cell Neoplasia: Its Possible Role as a New Prognostic Marker in B-CLL.

Lilla Cro, Nadia Zucal, Sonia Fabris, Antonino Neri, Marta Lionetti, Fortunato Morabito, Giovanna Cutrona, Manlio Ferrarini, Stefano Molica, Giorgio Lambertenghi Deliliers, Luca Baldini

Blood (2007) 110 (11): 4670.

https://doi.org/10.1182/blood.V110.11.4670.4670

Published: 2007

Journal Articles

Gene Expression Profiling of Plasma Cell Dyscrasias: The Role of IGH Translocations in the Heterogeneity of Multiple Myeloma.

Antonino Neri, MD, Michela Mattioli, PhD, Luca Agnelli, PhD, Sonia Fabris, PhD, Luca Baldini, MD, Fortunato Morabito, MD, Silvio Bicciato, PhD, Donata Verdelli, PhD, Daniela Intini, PhD, Lucia Nobili, PhD, Lilla Cro, PhD, Giancarlo Pruneri, MD, Vincenzo Callea, MD, Caterina Stelitano, MD, Luigia Lombardi, PhD

Blood (2004) 104 (11): 4845.

https://doi.org/10.1182/blood.V104.11.4845.4845

Published: 2004

Journal Articles

A Novel Chromosomal Translocation t(4; 14)(p16.3; q32) in Multiple Myeloma Involves the Fibroblast Growth-Factor Receptor 3 Gene

Raffaella Richelda, Domenica Ronchetti, Luca Baldini, Lilla Cro, Luigi Viggiano, Rosalia Marzella, Mariano Rocchi, Takemi Otsuki, Luigia Lombardi, Anna Teresa Maiolo, Antonino Neri

Blood (1997) 90 (10): 4062–4070.

https://doi.org/10.1182/blood.V90.10.4062

Published: 1997

NARROW

CD49d Is The Strongest Flow Cytometry-Based Predictor Of Overall Survival In Chronic Lymphocytic Leukemia

Prognostic Relevance of CD49d Expression On B Leukemic Cells in Chronic Lymphocytic Leukemia. Meta-Analysis of Published and unpublished Individual Data From 3146 Patients

Indolent B-Cell Lymphomas Treated Upfront with Antiviral Therapy: a Series of 13 Patients

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative.

Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors

The Cytofluorimetric/FISH Diagnostic Approach Define a B-Cell Variant-CLL with Peculiar Clinico-Biological Features.

CD26 Expression in Mature B-Cell Neoplasia: Its Possible Role as a New Prognostic Marker in B-CLL.

Gene Expression Profiling of Plasma Cell Dyscrasias: The Role of IGH Translocations in the Heterogeneity of Multiple Myeloma.

A Novel Chromosomal Translocation t(4; 14)(p16.3; q32) in Multiple Myeloma Involves the Fibroblast Growth-Factor Receptor 3 Gene

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only